You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 14, 2025

Drug Sales Trends for HYDROCORT


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for HYDROCORT (2021)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $1,813,282
INSIDE ANOTHER STORE $3,530,164
[disabled in preview] $7,932,580
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 129,887
INSIDE ANOTHER STORE 372,559
[disabled in preview] 1,235,404
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $4,379,391
MEDICARE $730,204
[disabled in preview] $8,166,430
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for HYDROCORT
Drug Units Sold Trends for HYDROCORT

Annual Sales Revenues and Units Sold for HYDROCORT

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
HYDROCORT ⤷  Try for Free ⤷  Try for Free 2021
HYDROCORT ⤷  Try for Free ⤷  Try for Free 2020
HYDROCORT ⤷  Try for Free ⤷  Try for Free 2019
HYDROCORT ⤷  Try for Free ⤷  Try for Free 2018
HYDROCORT ⤷  Try for Free ⤷  Try for Free 2017
HYDROCORT ⤷  Try for Free ⤷  Try for Free 2016
HYDROCORT ⤷  Try for Free ⤷  Try for Free 2015
>Drug Name >Revenues (USD) >Units >Year

Hydrocortisone Market Analysis and Sales Projections

Market Overview

The hydrocortisone market has been experiencing robust growth, driven by several key factors. These include the rising prevalence of skin disorders, an aging population, increased awareness and accessibility of healthcare, and significant investments in the pharmaceutical industry[1][4][5].

Current Market Size and Growth

As of 2023, the global hydrocortisone market was valued at approximately $1.43 billion. It is projected to grow to $1.52 billion in 2024, with a compound annual growth rate (CAGR) of 6.4%. By 2028, the market is expected to reach $1.96 billion, maintaining a CAGR of 6.6% during the forecast period[1].

Segmentation by Type

The hydrocortisone market is segmented into several types, including:

  • Cream: Widely used for topical applications, particularly for skin conditions such as dermatitis.
  • Injection: Used for parenteral administration, often in emergency situations or for severe conditions.
  • Tablet: Administered orally, commonly for systemic conditions like adrenocortical insufficiency[1][3][4].

Segmentation by Route of Administration

The market is also segmented based on the route of administration:

  • Parenteral: Injections administered directly into the bloodstream.
  • Oral: Tablets or capsules taken by mouth.
  • Topical: Creams, ointments, or gels applied directly to the skin[1][3][4].

Segmentation by Application

Hydrocortisone is used to treat a variety of conditions, including:

  • Adrenocortical Dysfunction
  • Adrenergic Syndrome
  • High Blood Calcium
  • Thyroiditis
  • Rheumatoid Arthritis
  • Dermatitis
  • Asthma and Chronic Obstructive Pulmonary Disease (COPD)
  • Other Applications such as allergic reactions and inflammatory conditions[1][3][4].

Segmentation by Distribution Channel

The distribution channels for hydrocortisone include:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies, which have seen significant growth due to increased online shopping trends[1][3][4].

Regional Analysis

The hydrocortisone market is analyzed across various regions:

  • North America: Accounts for a major share of the global market, driven by high healthcare spending and advanced medical infrastructure[4].
  • Europe: Significant market due to a large patient population and strong healthcare systems.
  • Asia-Pacific: Rapidly growing due to increasing healthcare expenditure and a large population base.
  • Latin America: Growing market driven by improving healthcare access and economic growth.
  • Middle East & Africa: Emerging markets with potential for significant growth in the forecast period[1][4].

Key Drivers and Trends

Several factors are driving the growth of the hydrocortisone market:

  • Rising Prevalence of Skin Disorders: Conditions like dermatitis and eczema are becoming more common, increasing the demand for hydrocortisone.
  • Aging Population: Older populations are more prone to various health conditions that require corticosteroid treatment.
  • Technological Advancements: Improvements in drug formulation and delivery techniques are enhancing the efficacy and safety of hydrocortisone products.
  • Increased Awareness and Accessibility: Greater awareness of health conditions and easier access to healthcare services are boosting market growth.
  • Natural Ingredient Focus: There is a growing trend towards natural ingredients, which may influence the development of hydrocortisone products.
  • Combination Therapies: The use of hydrocortisone in combination with other treatments is becoming more common, driving market expansion[1][4][5].

Market Projections

By 2028, the global hydrocortisone market is expected to reach $1.96 billion, with a CAGR of 6.6% from 2023 to 2028. This growth is attributed to ongoing technological advancements, a surge in over-the-counter (OTC) demand, increased research and development investments, growing disposable income, and expanded distribution channels[1].

Hydrocortisone Sodium Succinate Market

A specific segment of the hydrocortisone market is the hydrocortisone sodium succinate market, which was valued at $150 million in 2023. This market is projected to grow to $233.81 million by 2031, with a CAGR of 6% from 2024 to 2031. The growth in this segment is driven by the rising incidence of autoimmune and inflammatory diseases, advancements in drug formulation, and higher healthcare costs in emerging nations[5].

Key Takeaways

  • The hydrocortisone market is expected to grow significantly, driven by rising skin disorder prevalence, an aging population, and technological advancements.
  • The market is segmented by type, route of administration, application, and distribution channel.
  • Regional growth varies, with North America and Europe being major markets, and Asia-Pacific showing rapid growth.
  • Trends include a focus on natural ingredients, combination therapies, and personalized treatments.
  • The hydrocortisone sodium succinate market is also growing, driven by the need for efficient corticosteroid therapy in autoimmune and inflammatory diseases.

FAQs

1. What is the current size of the global hydrocortisone market?

The global hydrocortisone market was valued at approximately $1.43 billion in 2023[1].

2. What is the projected growth rate of the hydrocortisone market from 2023 to 2028?

The hydrocortisone market is expected to grow at a CAGR of 6.6% from 2023 to 2028[1].

3. Which regions are driving the growth of the hydrocortisone market?

North America, Europe, and the Asia-Pacific region are significant drivers of the hydrocortisone market, with the Asia-Pacific region showing rapid growth[1][4].

4. What are the main types of hydrocortisone products available?

The main types include cream, injection, and tablet forms[1][3][4].

5. What are some of the key trends in the hydrocortisone market?

Key trends include a focus on natural ingredients, combination therapies, personalized treatments, and an emphasis on sustainability[1].

Cited Sources:

  1. The Business Research Company: Global Hydrocortisone Market Report 2024.
  2. Valuates Reports: A-hydrocort - Market Report.
  3. Market Research Intellect: Global Hydrocortisone Market Size, Share, Outlook, Analysis and Forecast.
  4. Transparency Market Research: Hydrocortisone Market | Global Industry Report, 2028.
  5. Market Research Intellect: Hydrocortisone Sodium Succinate Market Size and Projections.
Last updated: 2024-12-31

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.